Variant report
Variant | esv3409133 |
---|---|
Chromosome Location | chr4:150811090-150811686 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13139249 | chr4:150811108-150811109 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536467184 | chr4:150811137-150811138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540222829 | chr4:150811178-150811179 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76644181 | chr4:150811200-150811201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539382535 | chr4:150811235-150811236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145690229 | chr4:150811236-150811237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551634222 | chr4:150811247-150811248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569799411 | chr4:150811252-150811253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139274108 | chr4:150811316-150811317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539357465 | chr4:150811322-150811323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558983211 | chr4:150811332-150811333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572407653 | chr4:150811340-150811341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561025836 | chr4:150811366-150811367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541025920 | chr4:150811367-150811368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72965326 | chr4:150811379-150811380 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs143194197 | chr4:150811389-150811390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147494390 | chr4:150811433-150811434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369888929 | chr4:150811438-150811439 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563511608 | chr4:150811496-150811497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs28380189 | chr4:150811499-150811500 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs552493643 | chr4:150811507-150811508 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559340632 | chr4:150811522-150811523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528100813 | chr4:150811560-150811561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12503905 | chr4:150811598-150811599 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs567694691 | chr4:150811600-150811601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536782453 | chr4:150811654-150811655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139305676 | chr4:150811686-150811687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:150806200-150820400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
2 | chr4:150806600-150818000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
3 | chr4:150808400-150812200 | Weak transcription | HSMM | muscle |
4 | chr4:150810000-150813200 | Enhancers | HSMMtube | muscle |
5 | chr4:150810400-150812200 | Enhancers | Fetal Intestine Large | intestine |
6 | chr4:150811000-150811200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr4:150811000-150811200 | Enhancers | Fetal Intestine Small | intestine |
8 | chr4:150811000-150812000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr4:150811000-150813200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr4:150811200-150811800 | Weak transcription | Fetal Intestine Small | intestine |
11 | chr4:150811600-150811800 | Enhancers | Osteobl | bone |